Technical Data
A0850
Actinomycin D (Streptomyces antibioticus, Dactinomycin, Actinomycin IV, Actinomycin C1)
25mg
100mg
500mg
100mg
500mg
|
Technical Data |
|
A0850 |
Actinomycin D (Streptomyces antibioticus, Dactinomycin, Actinomycin IV, Actinomycin C1) |
25mg 100mg 500mg |
| Biochemicals | Storage: 4°CShipping: RT |
|
Suitable for use in nucleic acid inhibition. Actinomycin D inhibits the proliferation of cells in a cell-cycle nonspecific way by forming a stable complex with DNA (via deoxyguanosine residues), thus inhibiting DNA-primed RNA synthesis. It is used in cell culture as a selection agent. Chemical Name: 2-Amino-(N,N)-1-bis(hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1]-[1,4,7,10,13]oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide Purity: 95% Appearance: Orange to red-brown crystaline powder Identity: Conforms to USP reference Potency: 900u/mg Specific Rotation:-292 to -317º Heavy Metals: <0.001% Loss on Drying: 5% RNase:None Detected DNase: None Detected Protease: None Detected Residue on Ignition: 0.1% Endotoxin: 100EU/mg Working concentration: 0.01 to 2ug/ml Solublility: Dimethyl sulfoxide (DMSO) 1mg/ml Light and moisture sensitive. CAS Number: 50-76-0 Molecular Formula: C62H86N12O16 Molecular Weight: 1255.43 |
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
US Biological application reference: Nelson, S.A. et al., (2000) Gene 253:87-93. 1. Merck Index, 11:441, #2804 (1989). 2. Meienhofer, J., J. Amer. Chem Soc., 92:3771 (1970). 3. United States Pharmacopoeia, XXII:379 (1990). 4. Singh, A.P.,et al., Can. J. Microbiol.,18 (6), 909 (1972).
|
||